Live Breaking News & Updates on Praxis Precision Medicines Company Profile

Stay updated with breaking news from Praxis precision medicines company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Praxis Precision Medicines (NASDAQ:PRAX) Given Buy Rating at Truist Financial

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Truist Financial in a report released on Thursday, Benzinga reports. They currently have a $150.00 target price on the stock. Truist Financial’s target price suggests a potential upside of 233.70% from the stock’s current price. PRAX has been […] ....

Robertw-baird , Jump-financial , Citigroup-inc , Jefferies-financial-group , Praxis-precision-medicines-inc , Praxis-precision-medicines-company-profile , York-mellon-corp , Connor-clark-lunn-investment-management-ltd , Simplex-trading , Praxis-precision-medicines , Get-free-report

Praxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at HC Wainwright

Praxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Praxis-precision-medicines-inc , Vanguard-group-inc , Praxis-precision-medicines-company-profile , Jefferies-financial-group , Sg-americas-securities , Chase-investment-counsel-corp , Praxis-precision-medicines , Free-report , Financial-group , Moderate-buy

Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 6.1%

Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 6.1%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Praxis-precision-medicines-inc , Sphera-funds-management , Vanguard-group-inc , Nasdaq , Jefferies-financial-group , Praxis-precision-medicines-company-profile , Praxis-precision-medicines , Get-free-report , Financial-group , Precision-medicines , Asset-management

Praxis Precision Medicines (NASDAQ:PRAX) Rating Reiterated by HC Wainwright

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a note issued to investors on Tuesday, Benzinga reports. They presently have a $105.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 77.54% from the stock’s current price. A number […] ....

Switzerland , Swiss , Praxis-precision-medicines-company-profile , York-mellon-corp , Metlife-investment-management , Jpmorgan-chase-co , Praxis-precision-medicines-inc , Swiss-national-bank , Praxis-precision-medicines , Get-free-report , Precision-medicines

Jefferies Financial Group Increases Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $128.00

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its target price boosted by equities researchers at Jefferies Financial Group from $75.00 to $128.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s price objective points to a potential upside […] ....

Jefferies-financial-group , Praxis-precision-medicines-inc , Sphera-funds-management , Vr-adviser , Praxis-precision-medicines-company-profile , Praxis-precision-medicines , Get-free-report , Financial-group , Precision-medicines , Praxis-precision , Asset-management